Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study
Titel:
Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study
Auteur:
Deterding, Katja Spinner, Christoph D Schott, Eckart Welzel, Tania M Gerken, Guido Klinker, Hartwig Spengler, Ulrich Wiegand, Johannes zur Wiesch, Julian Schulze Pathil, Anita Cornberg, Markus Umgelter, Andreas Zöllner, Caroline Zeuzem, Stefan Papkalla, Armin Weber, Kristina Hardtke, Svenja von der Leyen, Heiko Koch, Armin von Witzendorff, Dorothee Manns, Michael P Wedemeyer, Heiner